Table 4.
Comparison of clinicopathological factors between high splenic volume and low splenic volume group.
| High splenic volume (N=88) | Low splenic volume (N=45) | P value | |
|---|---|---|---|
| HBsAg (+), n (%) | 71 (80.7) 69 (78.4) |
35 (77.8) 25 (55.6) |
0.694 0.006 |
| Cirrhosis, n (%) | |||
| Platelet,103L (mean ± SD) |
145.06 ± 56.05 | 189.49 ± 55.92 | <0.001 |
| Tumor size, cm (mean ± SD) |
5.40 ± 3.78 | 4.43 ± 2.30 | 0.071 |
| AFP, ng/ml, n (%) ≤400 >400 |
68 (77.3) 20 (22.7) |
32 (71.1) 13 (28.9) |
0.436 |
| Tumor number, n (%) 1 >2 |
71 (80.7) 17 (19.3) |
38 (84.4) 7 (15.6) |
0.593 |
| MVI, n (%) No Yes |
60 (68.2) 28 (31.8) |
32 (71.1) 13 (28.9) |
0.729 |
| Satellitosis, n (%) | 10 (11.4) | 0 | 0.045 |
| BCLC staging, n (%) A B C |
71 (80.7) 11 (12.5) 6 (6.8) |
40 (88.9) 5 (11.1) 0 |
0.073 |
| Differentiation, n (%) Well Moderate Poor |
6 (6.8) 73 (83.0) 9 (10.2) |
4 (8.9) 30 (66.7) 11 (24.4) |
0.084 |
| Recurrence, n (%) | 33 (37.5) | 6 (13.3) | 0.004 |
Data are expressed as mean ± SD or n (%).
AFP, α-fetoprotein level; HBsAg, hepatitis be antigen; MVI, microvascular invasion; BCLC, Barcelona Clinic Liver Cancer.